[go: up one dir, main page]

IN192381B - - Google Patents

Info

Publication number
IN192381B
IN192381B IN1292DE2002A IN192381B IN 192381 B IN192381 B IN 192381B IN 1292DE2002 A IN1292DE2002 A IN 1292DE2002A IN 192381 B IN192381 B IN 192381B
Authority
IN
India
Application number
Inventor
Girish Jain
Seetharman Sritharan
Ashok Rampal
Original Assignee
Ranbaxy Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab filed Critical Ranbaxy Lab
Priority to IN1292DE2002 priority Critical patent/IN192381B/en
Priority to RU2005121999/15A priority patent/RU2005121999A/en
Priority to BR0317567-7A priority patent/BR0317567A/en
Priority to PCT/IB2003/006072 priority patent/WO2004056354A1/en
Priority to CNA2003801094133A priority patent/CN1744889A/en
Priority to CA002511208A priority patent/CA2511208A1/en
Priority to JP2004561893A priority patent/JP2006512358A/en
Priority to EP03780445A priority patent/EP1596849A1/en
Priority to AU2003288604A priority patent/AU2003288604A1/en
Publication of IN192381B publication Critical patent/IN192381B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IN1292DE2002 2002-12-20 2002-12-20 IN192381B (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IN1292DE2002 IN192381B (en) 2002-12-20 2002-12-20
RU2005121999/15A RU2005121999A (en) 2002-12-20 2003-12-18 PHARMACEUTICAL COMPOSITIONS OF TAMSULOSIN WITH CONTROLLED RELEASE
BR0317567-7A BR0317567A (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical composition of tamsulosin and process for its preparation
PCT/IB2003/006072 WO2004056354A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin
CNA2003801094133A CN1744889A (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin
CA002511208A CA2511208A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin
JP2004561893A JP2006512358A (en) 2002-12-20 2003-12-18 Tamsulosin controlled release pharmaceutical composition
EP03780445A EP1596849A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin
AU2003288604A AU2003288604A1 (en) 2002-12-20 2003-12-18 Controlled release pharmaceutical compositions of tamsulosin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1292DE2002 IN192381B (en) 2002-12-20 2002-12-20

Publications (1)

Publication Number Publication Date
IN192381B true IN192381B (en) 2004-04-10

Family

ID=32676755

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1292DE2002 IN192381B (en) 2002-12-20 2002-12-20

Country Status (9)

Country Link
EP (1) EP1596849A1 (en)
JP (1) JP2006512358A (en)
CN (1) CN1744889A (en)
AU (1) AU2003288604A1 (en)
BR (1) BR0317567A (en)
CA (1) CA2511208A1 (en)
IN (1) IN192381B (en)
RU (1) RU2005121999A (en)
WO (1) WO2004056354A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2515585A1 (en) * 2003-01-27 2004-08-12 Yoji Tanijiri Enteric sustained-release fine particles for tamsulosin or its salt and manufacturing method thereof
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
DK1618873T3 (en) * 2004-07-14 2007-10-08 Siegfried Generics Int Ag Granules for controlled release of tamsulosin, containing alginate
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101453996B (en) * 2006-04-03 2016-05-11 伊萨·奥迪迪 Drug delivery compositions
CN104825397A (en) 2006-04-03 2015-08-12 伊萨·奥迪迪 Controlled Release Delivery Devices Containing Organosol Coatings
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008089593A1 (en) * 2007-01-18 2008-07-31 Standard Chem. & Pharm. Co., Ltd. Sustained release tamsulosin formulation and producing method
EP2308483A4 (en) * 2008-07-01 2014-09-10 Sawai Seiyaku Kk Process for production of spherical microparticles comprising tamsulosin hydrochloride
CN101695478B (en) * 2009-10-23 2012-01-18 江苏大学 Tamsulosin hydrochloride sustained-release pellets and preparation method thereof
KR101423237B1 (en) 2010-05-04 2014-07-30 주식회사 삼양바이오팜 Release controlled pharmaceutical composition comprising tamsulosin or pharmaceutically acceptable salts thereof, and oral dosage form comprising the composition
CN103315962A (en) * 2013-02-01 2013-09-25 北京科信必成医药科技发展有限公司 Tamsulosin sustained-release pellet preparation and preparation method thereof
CN103142492A (en) * 2013-02-01 2013-06-12 北京科信必成医药科技发展有限公司 Controlled release pellet preparation and its preparation method
CN103919735B (en) * 2014-05-04 2018-04-17 翰宇药业（武汉）有限公司 A kind of tamsulosin hydrochloride sustained release pellet and preparation method thereof
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
KR20190019061A (en) * 2016-05-04 2019-02-26 아스펜 파크 파마슈티컬스 인코포레이티드 Delayed Release Oral Hydrochloride with Oral Administration
EP3473244A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
EP3473245A1 (en) 2017-10-20 2019-04-24 Veru Inc. Controlled release oral tamsulosin hydrochloride
KR20200078146A (en) * 2018-12-21 2020-07-01 한미약품 주식회사 Pharmaceutical compositions including tamsulosin hydrochloride excellent acid resistance and preparation method thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
HUP0401978A3 (en) * 2001-11-07 2008-07-28 Synthon Bv Tamsulosin tablets

Also Published As

Publication number Publication date
EP1596849A1 (en) 2005-11-23
BR0317567A (en) 2005-11-22
AU2003288604A1 (en) 2004-07-14
RU2005121999A (en) 2006-01-20
CA2511208A1 (en) 2004-07-08
CN1744889A (en) 2006-03-08
JP2006512358A (en) 2006-04-13
WO2004056354A1 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
BE2019C547I2 (en)
BE2019C510I2 (en)
BE2018C021I2 (en)
BE2017C049I2 (en)
BE2017C005I2 (en)
BE2016C069I2 (en)
BE2016C040I2 (en)
BE2016C013I2 (en)
BE2015C078I2 (en)
BE2016C002I2 (en)
BE2018C018I2 (en)
BE2015C017I2 (en)
BE2014C053I2 (en)
BE2014C051I2 (en)
BE2014C041I2 (en)
BE2014C030I2 (en)
BE2014C016I2 (en)
BE2014C015I2 (en)
BE2013C063I2 (en)
BE2015C067I2 (en)
JP2003106101A5 (en)
JP2003204563A5 (en)
IN192381B (en)
JP2003198654A5 (en)
JP2003123382A5 (en)